Correspondence

Methylphenidate-based drugs and phytocannabinoids: letter from Sarah Newton to the ACMD

Sarah Newton reponds to the Advisory Council on the Misuse of Drugs about its further advice on methylphenidate-based drugs and phytocannabinoids.